Matisse Capital’s 1Life Healthcare ONEM Stock Holding History

Matisse Capital’s Portfolio ONEM Stock Details ONEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-6,194	Closed	-$205K	–	170
2021 Q2	$205K	Hold	6,194	–	–	0.06%	138
2021 Q1	$242K	Buy	+6,194	New	+$291K	0.07%	144

Other funds holding ONEM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return

Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

OMC

Oak Management Corp Wilton, Connecticut $3.24M AUM 83.68% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Matisse Capital's ONEM Position: Q3 2021 in Review

Matisse Capital sold out of 1Life Healthcare (ONEM) in Q3 2021, closing a stake of 6,194 shares — an estimated $205K sold.

Matisse Capital first reported a position in ONEM in Q1 2021 and held it in 2 quarters. The position peaked at $242K in Q1 2021. 200 funds tracked by Wall St. Rank hold ONEM as of Q3 2021.

Matisse Capital reported no remaining 1Life Healthcare position as of Q3 2021 after selling out during the quarter.
Matisse Capital sold 6,194 1Life Healthcare shares in Q3 2021, an estimated $205K.
Matisse Capital first reported a position in 1Life Healthcare in Q1 2021 and held it in 2 quarters.
Matisse Capital's 1Life Healthcare position peaked at $242K in Q1 2021.
200 funds tracked by Wall St. Rank held 1Life Healthcare as of Q3 2021.

Based on Matisse Capital's 13F filing for Q3 2021, filed 8 Nov 2021.